Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules.

European journal of immunology - 1 Oct 2006

Webb Tonya J Roberts, Litavecz Roberta A, Khan Masood A, Du Wenjun, Gervay-Hague Jacquelyn, Renukaradhya Gourapura J, Brutkiewicz Randy R

Abstract excerpt

Vaccinia virus (VV) has been most commonly used as the vaccine to protect individuals against the causative agent of smallpox (variola virus), but it also uses a number of strategies meant to evade or blunt the host's antiviral immune response. Natural killer T (NKT) cells are a subset of immunoregulatory CD1d-restricted T lymphocytes believed to bridge the innate and adaptive immune responses. It is shown here...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to Antigens, CD1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens, CD1d

Share to Flow Cytometry

Share to Killer Cells, Natural

Share to Mitogen-Activated Protein Kinase Kinases

Share to Vaccinia virus

Share to Viral Proteins

Source

Identifiers

PMID: 16981180
DOI: 10.1002/eji.200636024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules.PMID 16981180Read ↗

Molecular Mechanisms of Immune Escape for Foot-and-Mouth Disease VirusSemantic proximity Read ↗

Recognition of Vaccinia Virus-Infected Cells by Human Natural Killer Cells Depends on Natural Cytotoxicity ReceptorsSemantic proximity Read ↗

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccinesSemantic proximity Read ↗

Generation and characterization of neutralizing antibodies against M1R and B6R proteins of monkeypox virusSemantic proximity Read ↗

Identification of Vaccinia Virus Inhibitors and Cellular Functions Necessary for Efficient Viral Replication by Screening Bioactives and FDA-Approved DrugsSemantic proximity Read ↗

Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune ResponseSemantic proximity Read ↗

Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T‐cell priming, and peptide association with MHC class IISemantic proximity Read ↗

Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell ResponsesSemantic proximity Read ↗

The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.Semantic proximity Read ↗

Viral soluble decoy receptor as a novel treatment for IFN-I triggered diseasesSemantic proximity Read ↗

Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling PathwaysSemantic proximity Read ↗

Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.